Zepbound Clinical Trial Findings

News

Zepbound beats Wegovy for weight loss

This drug led to 50% more weight loss than Wegovy in head-to-head study

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors find concerning. In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.

Becker's Hospital Review · 2d

Zepbound beats Wegovy for weight loss: Study

· 2d · on MSN

Zepbound outperforms Wegovy in head-to-head weight loss trial

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

New Atlas1d

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

The Boston Globe4d

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average ... who led the study and presented the findings Sunday at the European Congress on Obesity in Spain.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results